Independent Portfolio Consultants’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$8K Sell
120
-190
-61% -$11.7K ﹤0.01% 742
2017
Q1
$18K Hold
310
0.01% 669
2016
Q4
$19K Sell
310
-130
-30% -$8.47K 0.01% 632
2016
Q3
$30K Sell
440
-30
-6% -$1.98K 0.01% 609
2016
Q2
$26K Hold
470
0.01% 622
2016
Q1
$29K Hold
470
0.01% 636
2015
Q4
$30K Hold
470
0.01% 643
2015
Q3
$31K Sell
470
-190
-29% -$13.4K 0.01% 644
2015
Q2
$45K Sell
660
-330
-33% -$20.9K 0.01% 636
2015
Q1
$55K Buy
+990
New +$50.7K 0.01% 607
2014
Q2
Sell
-10,540
Closed -$397K 841
2014
Q1
$397K Buy
10,540
+160
+2% +$5.59K 0.13% 306
2013
Q4
$392K Buy
10,380
+750
+8% +$28.7K 0.14% 311
2013
Q3
$418K Sell
9,630
-150
-2% -$6.02K 0.17% 269
2013
Q2
$354K Buy
+9,780
New +$297K 0.16% 287

Other funds holding USNA

Independent Portfolio Consultants's USNA Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its Usana Health Sciences (USNA) stake by 61% in Q2 2017, selling an estimated $11.7K and leaving 120 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #742.

Independent Portfolio Consultants first reported a position in USNA in Q2 2013 and has held it in 14 quarters since. The position peaked at $418K in Q3 2013. 145 funds tracked by Wall St. Rank hold USNA as of Q2 2017.

  • Independent Portfolio Consultants held 120 shares of Usana Health Sciences worth $8K as of Q2 2017.
  • Independent Portfolio Consultants sold 190 Usana Health Sciences shares in Q2 2017, an estimated $11.7K.
  • Usana Health Sciences made up ﹤0.01% of Independent Portfolio Consultants's portfolio in Q2 2017, its #742 holding.
  • Independent Portfolio Consultants first reported a position in Usana Health Sciences in Q2 2013 and has held it in 14 quarters since.
  • Independent Portfolio Consultants's Usana Health Sciences position peaked at $418K in Q3 2013.
  • 145 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.